NEW YORK (TheStreet) -- Shares of AmerisourceBergen (ABC - Get Report) are lower by 0.07% to $85.13 on Monday afternoon ahead of the company's 2016 fiscal third quarter earnings, due out before tomorrow's market open.

Wall Street is expecting that earnings per share and revenue will increase year-over-year

Analysts are projecting that the pharmaceutical sourcing and distribution services company will report earnings of $1.27 per share on revenue of $36.71 billion.

During the same quarter last year, the Valley Forge, PA-based company earned $1.20 per diluted share on revenue of $34.23 billion.

Separately, TheStreet Ratings Team has a "Buy" rating with a score of B on the stock.

The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, notable return on equity, good cash flow from operations and impressive record of earnings per share growth.

The team believes its strengths outweigh the fact that the company has had generally high debt management risk by most measures that were evaluated.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: ABC